Followers | 79 |
Posts | 1668 |
Boards Moderated | 0 |
Alias Born | 08/26/2008 |
Saturday, June 07, 2014 11:27:32 AM
But look around, BP's (big pharma) all started out long ago, many MA's and outright buy outs took place to make them who they are today. The longer they've been around the larger the PS and the more $$
they have to play with.
Large BP's don't always do their own research into new technology, they depend upon smaller co.'s doing this and watch them very closely and strike when they feel they can acquire them on the cheap or when the technology is such they can carry forward. This is done all the time.
As for me suggesting a co. to you, this is something I would never do. I have been wrong on many occasions and would hate to be a part of another's failure.
I would however take a look at some of the boards I frequent and read some of the other posts in this arena.
Lots of money can be made quickly and lots can be lost just as quickly.
It's all upon one's preference.
Best of luck to you in your quest.
BTW, I gave you a member mark yesterday.
Recent OMER News
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results • Business Wire • 04/01/2024 08:02:00 PM
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024 • Business Wire • 03/27/2024 12:30:00 PM
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy • Business Wire • 02/20/2024 02:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:05:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:00:23 PM
- Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust • Business Wire • 02/01/2024 02:11:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/29/2024 08:26:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 01:11:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2023 02:46:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 02:55:18 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:06:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:05:36 PM
- Omeros Corporation Reports Third Quarter 2023 Financial Results • Business Wire • 11/09/2023 09:02:00 PM
- Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023 • Business Wire • 11/06/2023 01:00:00 PM
- Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy • Business Wire • 11/03/2023 01:05:00 PM
- Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting • Business Wire • 11/02/2023 01:05:00 PM
- Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer • Business Wire • 10/19/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:36:07 PM
- Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy • Business Wire • 10/16/2023 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 09:02:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 08:56:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 08:53:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/20/2023 08:47:29 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM